These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 31985548)

  • 21. High CXCR4 expression correlates with sunitinib poor response in metastatic renal cancer.
    D' Alterio C; Portella L; Ottaiano A; Rizzo M; Carteni G; Pignata S; Facchini G; Perdona S; Di Lorenzo G; Autorino R; Franco R; La Mura A; Nappi O; Castello G; Scala S
    Curr Cancer Drug Targets; 2012 Jul; 12(6):693-702. PubMed ID: 22463589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of chemokine CXCL12 and its receptor CXCR4 in human epithelial ovarian cancer: an independent prognostic factor for tumor progression.
    Jiang YP; Wu XH; Shi B; Wu WX; Yin GR
    Gynecol Oncol; 2006 Oct; 103(1):226-33. PubMed ID: 16631235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary tumor location and bevacizumab effectiveness in patients with metastatic colorectal cancer.
    Boisen MK; Johansen JS; Dehlendorff C; Larsen JS; Østerlind K; Hansen J; Nielsen SE; Pfeiffer P; Tarpgaard LS; Holländer NH; Keldsen N; Hansen TF; Jensen BB; Jensen BV
    Ann Oncol; 2013 Oct; 24(10):2554-2559. PubMed ID: 23864097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CXCR4 overexpression is correlated with poor prognosis in colorectal cancer.
    Xu C; Zheng L; Li D; Chen G; Gu J; Chen J; Yao Q
    Life Sci; 2018 Sep; 208():333-340. PubMed ID: 29719205
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiogenic and Antiangiogenic VEGFA Splice Variants in Colorectal Cancer: Prospective Retrospective Cohort Study in Patients Treated With Irinotecan-Based Chemotherapy and Bevacizumab.
    Pentheroudakis G; Mavroeidis L; Papadopoulou K; Koliou GA; Bamia C; Chatzopoulos K; Samantas E; Mauri D; Efstratiou I; Pectasides D; Makatsoris T; Bafaloukos D; Papakostas P; Papatsibas G; Bombolaki I; Chrisafi S; Kourea HP; Petraki K; Kafiri G; Fountzilas G; Kotoula V
    Clin Colorectal Cancer; 2019 Dec; 18(4):e370-e384. PubMed ID: 31402291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CXC receptor 4 and stromal cell-derived factor 1 in primary tumors and liver metastases of colorectal cancer.
    Yamada S; Shimada M; Utsunomiya T; Morine Y; Imura S; Ikemoto T; Mori H; Arakawa Y; Kanamoto M; Iwahashi S; Saito Y
    J Surg Res; 2014 Mar; 187(1):107-12. PubMed ID: 24238971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. KRAS Status as an Independent Prognostic Factor for Survival after Yttrium-90 Radioembolization Therapy for Unresectable Colorectal Cancer Liver Metastases.
    Lahti SJ; Xing M; Zhang D; Lee JJ; Magnetta MJ; Kim HS
    J Vasc Interv Radiol; 2015 Aug; 26(8):1102-11. PubMed ID: 26210240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinicopathologic and prognostic significance of immunohistochemical expression of HIF-1α, CXCR4 and CA9 in colorectal carcinoma.
    Saka B; Ekinci O; Dursun A; Akyurek N
    Pathol Res Pract; 2017 Jul; 213(7):783-792. PubMed ID: 28554753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of survival and prognostic factors in metastatic colorectal cancer patients treated with first-line bevacizumab-based therapy.
    Demircan NC; Dane F; Ozturk MA; Babacan NA; Besiroglu M; Kaya S; Ercelep O; Tanrikulu E; Halil S; Koca S; Alan O; Hasanov R; Yumuk PF
    J BUON; 2019; 24(4):1494-1500. PubMed ID: 31646797
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognosis and Clinicopathology of CXCR4 in Colorectal Cancer Patients: a Meta-analysis.
    Li LN; Jiang KT; Tan P; Wang AH; Kong QY; Wang CY; Lu HR; Wang J
    Asian Pac J Cancer Prev; 2015; 16(9):4077-80. PubMed ID: 25987090
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prognostic significance and impact of the CXCR4-CXCR7-CXCL12 axis in primary cutaneous melanoma.
    McConnell AT; Ellis R; Pathy B; Plummer R; Lovat PE; O'Boyle G
    Br J Dermatol; 2016 Dec; 175(6):1210-1220. PubMed ID: 27167239
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.
    Song A; Eo W; Lee S
    World J Gastroenterol; 2015 Nov; 21(43):12410-20. PubMed ID: 26604648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer.
    Stanisavljević L; Myklebust MP; Leh S; Dahl O
    Acta Oncol; 2016 Dec; 55(12):1425-1433. PubMed ID: 27435662
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CXCR4/CXCL12 expression profile is associated with tumor microenvironment and clinical outcome of liver metastases of colorectal cancer.
    Sakai N; Yoshidome H; Shida T; Kimura F; Shimizu H; Ohtsuka M; Takeuchi D; Sakakibara M; Miyazaki M
    Clin Exp Metastasis; 2012 Feb; 29(2):101-10. PubMed ID: 22075627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of the chemokine receptor CXCR4 correlates with a favorable prognosis in patients with adenocarcinoma of the lung.
    Minamiya Y; Saito H; Takahashi N; Ito M; Imai K; Ono T; Motoyama S; Ogawa J
    Lung Cancer; 2010 Jun; 68(3):466-71. PubMed ID: 19716197
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CXCR7 expression is associated with disease-free and disease-specific survival in cervical cancer patients.
    Schrevel M; Karim R; ter Haar NT; van der Burg SH; Trimbos JB; Fleuren GJ; Gorter A; Jordanova ES
    Br J Cancer; 2012 Apr; 106(9):1520-5. PubMed ID: 22531719
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemokine receptor CCR7 expression predicts poor outcome in uveal melanoma and relates to liver metastasis whereas expression of CXCR4 is not of clinical relevance.
    van den Bosch T; Koopmans AE; Vaarwater J; van den Berg M; de Klein A; Verdijk RM
    Invest Ophthalmol Vis Sci; 2013 Nov; 54(12):7354-61. PubMed ID: 24052640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ERCC1 and TS Expression as Prognostic and Predictive Biomarkers in Metastatic Colon Cancer.
    Choueiri MB; Shen JP; Gross AM; Huang JK; Ideker T; Fanta P
    PLoS One; 2015; 10(6):e0126898. PubMed ID: 26083491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CXCR4 as a prognostic biomarker in gastrointestinal cancer: a meta-analysis.
    Jiang Q; Sun Y; Liu X
    Biomarkers; 2019 Sep; 24(6):510-516. PubMed ID: 31244335
    [No Abstract]   [Full Text] [Related]  

  • 40. The association of CXCR4 expression with prognosis and clinicopathological indicators in colorectal carcinoma patients: a meta-analysis.
    Lv S; Yang Y; Kwon S; Han M; Zhao F; Kang H; Dai C; Wang R
    Histopathology; 2014 Apr; 64(5):701-12. PubMed ID: 24422942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.